Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia
Agnieszka Nikiforuk, Małgorzata Hołuj, Tomasz Kos, et al.
Neuropharmacology (2016) Vol. 105, pp. 351-360
Closed Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Current Concepts and Treatments of Schizophrenia
Piotr Stępnicki, Magda Kondej, Agnieszka A. Kaczor
Molecules (2018) Vol. 23, Iss. 8, pp. 2087-2087
Open Access | Times Cited: 463
The Roles of Serotonin in Neuropsychiatric Disorders
Mahsa Pourhamzeh, Fahimeh Ghasemi Moravej, Mehrnoosh Arabi, et al.
Cellular and Molecular Neurobiology (2021) Vol. 42, Iss. 6, pp. 1671-1692
Closed Access | Times Cited: 212
International Union of Basic and Clinical Pharmacology. CX. Classification of Receptors for 5-hydroxytryptamine; Pharmacology and Function
Nicholas M. Barnes, Gerard P. Ahern, Carine Bécamel, et al.
Pharmacological Reviews (2020) Vol. 73, Iss. 1, pp. 310-520
Open Access | Times Cited: 204
NMDA receptor antagonist rodent models for cognition in schizophrenia and identification of novel drug treatments, an update
Daniela Cadinu, B. Terence Grayson, Giovanni Podda, et al.
Neuropharmacology (2017) Vol. 142, pp. 41-62
Open Access | Times Cited: 145
The profile of cognitive impairments in chronic ketamine users
Xiaoyin Ke, Yi� Ding, Ke Xu, et al.
Psychiatry Research (2018) Vol. 266, pp. 124-131
Closed Access | Times Cited: 55
Reduced Frontoparietal Activity in Schizophrenia Is Linked to a Specific Deficit in Goal Maintenance: A Multisite Functional Imaging Study
Andrew Poppe, Deanna M. Barch, Cameron S. Carter, et al.
Schizophrenia Bulletin (2016) Vol. 42, Iss. 5, pp. 1149-1157
Open Access | Times Cited: 52
A transnosographic approach of negative symptoms pathophysiology in schizophrenia and depressive disorders
Sélim Benjamin Guessoum, Yann Le Strat, Caroline Dubertret, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2020) Vol. 99, pp. 109862-109862
Open Access | Times Cited: 42
Cognitive Deficit in Schizophrenia: From Etiology to Novel Treatments
Antón L. Martínez, José Brea, Sara Rico, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 18, pp. 9905-9905
Open Access | Times Cited: 34
Structure-Based Design of a Chemical Probe Set for the 5-HT5A Serotonin Receptor
Anat Levit, Ryan T. Strachan, João M. Bráz, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 5, pp. 4201-4217
Open Access | Times Cited: 25
Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects
Paweł Zajdel, Tomasz Kos, Krzysztof Marciniec, et al.
European Journal of Medicinal Chemistry (2018) Vol. 145, pp. 790-804
Closed Access | Times Cited: 44
Impact of specific serotonin receptor modulation on behavioral flexibility
Bryan D. Alvarez, Cheyenne A. Morales, Dionisio A. Amodeo
Pharmacology Biochemistry and Behavior (2021) Vol. 209, pp. 173243-173243
Open Access | Times Cited: 31
Past, present, and future of serotonin-targeting therapeutics for Alzheimer’s Disease: perspectives from DNA methylation
Yanzhi Liu, Luca Aquili, Kah-Hui Wong, et al.
Ageing Research Reviews (2025), pp. 102755-102755
Closed Access
The Role of the N-Methyl-D-Aspartate Receptors in Social Behavior in Rodents
Iulia Zoicas, Johannes Kornhuber
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 22, pp. 5599-5599
Open Access | Times Cited: 30
Vortioxetine improved negative and cognitive symptoms of schizophrenia in subchronic MK-801 model in rats
Nuh Mehmet Bozkurt, Gökhan Ünal
Behavioural Brain Research (2023) Vol. 444, pp. 114365-114365
Closed Access | Times Cited: 10
Nicotinate‐curcumin ameliorates cognitive impairment in diabetic rats by rescuing autophagic flux in CA1 hippocampus
Hong‐Feng Gu, Na Li, Yaling Tang, et al.
CNS Neuroscience & Therapeutics (2018) Vol. 25, Iss. 4, pp. 430-441
Open Access | Times Cited: 31
Serotonin transporter deficiency alters socioemotional ultrasonic communication in rats
Joanna Gołębiowska, Małgorzata Hołuj, Agnieszka Potasiewicz, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 27
Astrocyte Activation, but not Microglia, Is Associated with the Experimental Mouse Model of Schizophrenia Induced by Chronic Ketamine
Ying Wei, Li Xiao, Weihao Fan, et al.
Journal of Molecular Neuroscience (2022) Vol. 72, Iss. 9, pp. 1902-1915
Closed Access | Times Cited: 14
Current development in sulfonamide derivatives to enable CNS-drug discovery
Klaudia Blicharz-Futera, Michał Kamiński, Katarzyna Grychowska, et al.
Bioorganic Chemistry (2024) Vol. 156, pp. 108076-108076
Closed Access | Times Cited: 2
Classification and signaling characteristics of 5-HT receptors: toward the concept of 5-HT receptosomes
Philippe Marin, Carine Bécamel, Séverine Chaumont‐Dubel, et al.
Handbook of behavioral neuroscience (2020), pp. 91-120
Open Access | Times Cited: 16
Frameworking memory and serotonergic markers
Alfredo Meneses
Reviews in the Neurosciences (2017) Vol. 28, Iss. 5, pp. 455-497
Closed Access | Times Cited: 18
Mechanism of psychoactive substance-induced cognitive disorders: does tau protein play a role?
Yuye Wang, JiaCheng Lv, Jining He, et al.
Frontiers in Bioscience-Landmark (2022) Vol. 27, Iss. 1
Open Access | Times Cited: 8
Comprehensive metabolomic characterization of the hippocampus in a ketamine mouse model of schizophrenia
Ying Wei, Li Xiao, Weihao Fan, et al.
Biochemical and Biophysical Research Communications (2022) Vol. 632, pp. 150-157
Closed Access | Times Cited: 6
Effects of 5-HT5A receptor blockade on amnesia or forgetting
L. Aparicio-Nava, L.A. Márquez-García, A. Meneses
Behavioural Brain Research (2018) Vol. 357-358, pp. 98-103
Closed Access | Times Cited: 9
Functional mechanism of ASP5736, a selective serotonin 5-HT5A receptor antagonist with potential utility for the treatment of cognitive dysfunction in schizophrenia
Mayako Yamazaki, Noriyuki Yamamoto, Junko Yarimizu, et al.
European Neuropsychopharmacology (2018) Vol. 28, Iss. 5, pp. 620-629
Open Access | Times Cited: 9
Discovery and Development of Non-Dopaminergic Agents for the Treatment of Schizophrenia: Overview of the Preclinical and Early Clinical Studies
Agnieszka Jankowska, Grzegorz Satała, Anna Partyka, et al.
Current Medicinal Chemistry (2019) Vol. 26, Iss. 25, pp. 4885-4913
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top